Special Issue Title:

Biotechnologies, Imaging Modalities and Analysis Methodologies for Probing the Breast Cancer

Deadline for manuscript submissions: 01 June 2023

Print Special Issue Flyer (2)

Special Issue Editor

  • Guest Editor

    Yu Shang, PhDE-MailWebsite

    Professor, Department of Biomedical Engineering, North University of China, Taiyuan, China

    Interests: Biomedical Engineering

  • Guest Editor

    Shun Wan Chan, PhDE-MailWebsite

    Associate Professor, Head of Department of Food and Health Sciences, Technological and Higher Education Institution of Hong Kong, Chai Wan, Hong Kong, China

    Interests: Biotechnology

Special Issue Information

Dear Colleagues,


Breast cancer is the most threatening malignant tumor for women worldwide. According to the global cancer statistics, both the occurrence rate and mortality rate of breast cancer rank first among the female population, with 24.2% and 15.0% respectively. Early screening and identifying of breast cancer offer early opportunities for patients to receive timely treatments, thus elevating the survival rate and improving the life quality. 


Imaging modalities, such as X-ray mammography, breast ultrasonography, and magnetic resonance imaging (MRI), are the most frequently-used approaches for screening of breast cancers in clinic. Nevertheless, none of these modalities is ideal to combine multiple advantages such as high sensitivity and specificity, low cost as well as fast measurement. The biopsy test is the golden standard to identify the cancerous cells, which, however, due to the disadvantage of invasiveness, only serves as the last option for patients suffering from breast diseases. 


Seeking for the ideal approaches to probe breast cancer is always the effort for both scientists and clinicians. In recent year, a few technologies are emerging, as opposed to the conventional approaches, for probing the breast cancer, either invasively or noninvasively. For example, fluorescence technology has been developed to identify the cancer cells, which are known to overexpress Glut5, a sugar transporter accounting for the transfer of fructose across the cell membrane. Because Glut5 transporter is not overexpressed in healthy breast cells, the fluorescent-tagged fructose could be used to differentiate between healthy and cancerous cells. Another alternative for breast cancer detection is functional imaging. For example, the near-infrared diffuse optical/correlation tomography (DOT/DCT) have been developed to probe the abnormal tissue blood flow/oxygenation/oxygen metabolism. Because the cancerous cells are with the feature of abnormally higher metabolic demands, subsequently elevating the microcirculation and causing the poor oxygen status. Those functional abnormalities caused by the cancerous cells often appear earlier than the morphological changes that are detectable by the conventional imaging modalities. Hence, the functional imaging offers a new strategy for early screening of the breast cancer. 


In addition to the biotechnologies and imaging modalities mentioned above, the advanced data analysis methods are emerging, in recent years, with aim to assist the diagnosis of breast cancer through integrating a variety of measuring modalities and numerous parameters. The data analysis methods, particularly those combing with the artificial intelligence (AI), have promising potential for future detection of breast cancer. 


To promote the latest progress in the creation, development and clinical usage of various approaches for probing the breast cancer, we invite the submission of original research or review articles to Special Issue of European Journal of Gynaecological Oncology. This special issue is planned to cover all of the new principles, technologies, or applications of the possible methodologies or strategies that will benefit for diagnosis or earlier screening of the breast cancer.


Yu Shang, PhD and Shun Wan Chan, PhD

Guest Editors

Keywords

Breast Cancer; Imaging; Biotechnology; Data Analysis

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access journal published by MRE Press. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Plan Papers (0 papers)

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences